Alnylam Pharmaceuticals, Inc. logo

Alnylam Pharmaceuticals

ALNY

Healthcare
NASDAQ
US

About Alnylam Pharmaceuticals

Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on gene…

Power Profile

Revenue Counter

Alnylam Pharmaceuticals earns $117.77/sec (TTM: $3.71B)

Revenue counter

Earnings Counter

Alnylam Pharmaceuticals earns $9.95/sec net profit (TTM: $313.75M)

Earnings counter

Economic Scale

Alnylam Pharmaceuticals revenue exceeds Curacao GDP ($3.6B)

Economic scale

What If Invested

See what $1,000 invested in Alnylam Pharmaceuticals would be worth today

What if invested

How it makes money

Visual revenue breakdown: how Alnylam Pharmaceuticals generates income and where it flows

How it makes money

Seasonality

Monthly and quarterly returns heatmap, seasonality matrix for Alnylam Pharmaceuticals

View seasonality
Q1 2026
Report Date
Apr 30, 2026
BMO
Lock in
43 days 4 hours
Revenue
Analyst Forecast
$1.13B
EPS
Analyst Forecast
1.59